Research is focusing on the molecular pathology of lung cancer as a key to personalized medicine. Studies are exploring various aspects, including diagnostics, organoids, and biomarker testing, to advance precision cancer therapy. The field of personalized oncology is also examining the role of technologies like AI and the disparities in access to biomarker testing among different patient populations.